Sunday, December 17, 2017 2:46:37 PM
Well at least taug is consistent as proven by their wasting one quarter of the settlement with Cowan--with the investment in this pharmaceutical company. This is reminiscent of ITL which ended up as worthless and the drug this company is trying to develop is only in phase 2 so even if it succeeds it will be years before this would occur.
But taug does have something in common with the company they have invested in---namely a stock chart that has gone down steadily.
IMO the investment will fail and the lip goop will fail just like did the wellness business. Just like the wellness business the price of the products are too high and the marketing is a disaster--and to boot even if the goop sells it will be ice and jam and not taug which will benefit.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM